1,3-diaryl cyclopentanes and derivatives thereof as PAF antagoni

Details 1,3-diaryl cyclopentanes and derivatives thereof as PAF antagoni 1,3-diaryl cyclopentanes and derivatives thereof as PAF antagoni

1991-06-12

1992-07-21

Cintins, Marianne

Organic compounds -- part of the class 532-570 series

Organic compounds

Sulfur containing

568 29, 568 34, C07C31714, C07C31722

Patent

active

051324636

ABSTRACT:
Novel 1,3-Diaryl cyclopentanes of the following general formula were prepared. ##STR1## These compounds were found to have potent and specific PAF (Platelet Activating Factor) antagonistic activities and as such useful in the treatment or amelioration of various diseases or disorders mediated by the PAF, for example, hypotension, inflammation, nephritis, stroke and other cardiovascular disorders, asthma, allergic and skin diseases, peptic or stomach ulcer, shock, lung edema, psoriasis, adult respiratory distress syndrome, pain including dental pain, and aggregation of platelets.

REFERENCES:
patent: 4845129 (1989-07-01), Anderson et al.
patent: 5047420 (1991-09-01), Graham
P. Ruggli et al., J.O.C., 26, 307 (1961).
Strashneuko et al., 2h Org. Khim., 3, 91 (1967).
D. H. Richards et al., J. Chem. Soc. (c) 2661 (1969).

Affiliated with

Also associated with

Rating

1,3-diaryl cyclopentanes and derivatives thereof as PAF antagoni does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,3-diaryl cyclopentanes and derivatives thereof as PAF antagoni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-diaryl cyclopentanes and derivatives thereof as PAF antagoni will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-844857